Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions

This publication has 23 references indexed in Scilit:

• 'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy.
  Published by Oxford University Press (OUP) ,2002
• Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion
  European Heart Journal, 1999
• Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
  European Heart Journal, 1999
• New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence
  European Heart Journal, 1999
• Management of Symptomatic Hypertrophic Obstructive Cardiomyopathy - Long-Term Results after Surgical Therapy
  The Thoracic and Cardiovascular Surgeon, 1999
• Real-time transmission of echocardiographic images over high speed networks: effects of bandwidth, cell loss ratio and cell error ratio on image quality
  Journal of the American College of Cardiology, 1998
• Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population
  Journal of the American College of Cardiology, 1995
• Utility of continuous wave doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy
  Journal of the American College of Cardiology, 1992
• Hypertrophic Cardiomyopathy
  New England Journal of Medicine, 1987
• Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
  Progress in Cardiovascular Diseases, 1985